Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia
Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia作者机构:Dept HematolShanghai Instit HematolRuijin HospShanghai Jiaotong Univ Med Sch
出 版 物:《China Medical Abstracts(Internal Medicine)》 (中国医学文摘(内科学分册(英文版))
年 卷 期:2013年第30卷第2期
页 面:123-123页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:myeloid cumulative pleural median mostly edema versus effusion option statistic
摘 要:Objective To compare the efficacy and safety of dasatinib and imatinib in patients with newly diagnosed chronic phase chronic myeloid leukemia(CML-CP).Methods37CML-CP patients were randomized to